Echo | Angio | ECG | X-Ray/MRI | Clinical Trials | Guidelines | Drug Info |  Journals  | Events | Interesting Cases

Welcome May 19, 2013
Search News by Date
  



Hygia Project: ingestion of full doses of hypertension medications at bedtime is a proper chronotherapeutic approach and shown to result in improved ambulatory BP control and fewer cardiovascular events

Although all of the chronotherapy trials so far compared the effects of full medication doses on blood pressure (BP) regulation, that were ingested either in the morning or at bedtime, still the trend for the prescription of the same medication(s) as twice-daily divided (BID) doses is frequent.

To throw more light on this issue, Dr. Hermida Ramon Cand coworkers performed the present study that investigated the effects of ingesting split doses of the same hypertension medication, half upon awakening and half at bedtime, on the BP pattern and degree of BP control of patients with resistant hypertension who were enrolled in the Hygia Project, that was designed to prospectively evaluate the cardiovascular risk by 48 hrs ambulatory BP monitoring (ABPM) in primary care centers of Northwest Spain.

Study population consisted of 1463 patients with true resistant hypertension (awake systolic [SBP]/diastolic BP [DBP] means >135/85 mmHg, or asleep SBP/DBP means >120/70 mmHg, while on 3 different hypertension medications, or any patient treated with >4 medications).  Among the total enrolled, 809 were men/654 were women. Mean age was 63.9 ± 12.2 years.

1084 among the enrollees ingested the full dose of all BP-lowering medications upon awakening, and 379 ingested split doses of >1 medications BID upon awakening and at bedtime.

Findings from this study showed most of demographic characteristics that included the prevalence of obstructive sleep apnea, metabolic syndrome, and albuminuria were similar among the patients of the two treatment-time regimens.

Complete comparable results were shown by the awake and asleep SBP/DBP mean’s (awake SBP/DBP mean 137.4/78.8 vs. 138.9/77.5 mmHg for patients ingesting all medications upon awakening vs. BID split dosing of >1 medications, P > 0.074; asleep SBP/DBP mean 132.3/71.9 vs. 132.9/70.7 mmHg, P > 0.079). Similarly, fully comparable results between both treatment-time regimens were shown in terms of the prevalence of non-dipping (80.5 vs. 77.3%; P = 0.179) and the proportion of patients with controlled ambulatory BP (P = 0.114).

Notably, no improvements in ambulatory BP control, or reductions in the prevalence of non-dipping were reported with the ingestion of same medications BID as a split dose regimen in patients with resistant hypertension, hence this dose regimen could not be considered as chronotherapy.

In conclusion this study demonstrated that ingestion of full doses of hypertension medications at bedtime is a proper chronotherapeutic approach that shown to result in improved ambulatory BP control and fewer hard and soft cardiovascular events.

 


Source:ASH 2012
Compiled and edited by the Editorial team and approved by Expert panel of CardioValens.com

 Other News
First study to evaluate the effectiveness of Functional Electrical Stimulation on exercise capacity, endothelial function and echocardiographic indices of diastolic function in chronic heart failure patients with preserved systolic function
Higher predictive value for malignant ventricular arrhythmias and complex end point for patients with dilated nonischaemic cardiomyopathy and chronic heart failure
Association between hyperglycemia and adverse outcomes observed in AMI patients does not hold true in patients hospitalized with other cardiovascular conditions
Presence of septal asymmetric Hypertrophic cardiomyopathy type is the only independent predictor of increased right atrial volume index
Excellent post-transplant outcomes with mechanical circulatory support as bridge to heart transplantation
Significantly decreased degree of mitral regurgitation or an improved mitral regurgitation, reverse remodeling of left atrium and decrease in left atrium diameters are the benefits with cardiac resynchronization therapy
Myocardial lipid content correlates inversely with left ventricular function in heart failure patients with type 2 diabetes
Periodic use of levosimendan in outpatients with end-stage chronic heart failure is safe and effective in improving quality of life and in reducing re-admissions for worsening heart failure at least in the first eight months of therapy
Highly prevalent severe interatrial mechanical delay in heart failure with preserved ejection fraction is associated with shorter mitral A wave and higher filling pressures
Presence of microalbuminuria is a potential risk marker of events in patients admitted with ACS
The CARILLION® Mitral Contour System implanted in heart failure patients with functional mitral regurgitation provide clinical improvements
Digoxin in high risk Heart Failure patients with reduced ejection fractions
Co-relation between blood pressure/body composition and exercise in hypertensive older overweight individuals
Gender wise analysis of hypertensive patients under a stabilized therapy and without a history of cardiovascular events shows significant differences in the prediction of either stroke or global cardiovascular events or even both
ARB-based aggressive antihypertensive therapy guided by home BP monitoring in patients with diabetes/pre-diabetes is effective in improving cardiovascular target damage
Hypoadiponectinemia and high aldosterone levels in arterial rigidity are responsible for resistance to an antihypertensive therapy
Total cholesterol control can be predicted by only younger age for management of childhood dyslipidemia and hypertension and prevention
Impact of the Combination Antihypertensive Therapy with inclusion of Atorvastatin and Metformin on insulin resistance parameters in patients with the metabolic syndrome and fasting hyperinsulinemia
The combination treatment with Telmisartan, Torasemid and Atorvastatin has positive effects on blood pressure levels and reduces the intensity of heart failure progression in hypertensive's with heart failure class II-III NYHA
Subjects with masked hypertension have an early alteration of diastolic dysfunction
Associations of an increasing plasma insulin levels in patients with metabolic syndrome and post-infarction cardio-sclerosis
Reflected pressure waves in the arm in contrast to central systolic BP do not contribute to the measured arm cuff systolic BP measurements except in Stage 2 hypertension and thereby do not typically influence the diagnosis or staging of systolic hypertension

About Us | Disclaimer |  Privacy Statement | Advertising Info 
info@centrixhealthcare.com © Copyright 2000-2013 Centrix Healthcare Inc. - All Rights Reserved.